COVID-19 and β-thalassemia: in lieu of evidence and vague nexus Hayder M. Al-KuraishyMohamed H. Mazhar AshourGaber El-Saber Batiha Review Article 05 July 2023 Pages: 1423 - 1433
Epigenetic alterations and advancement of lymphoma treatment Shuhui ZhuangZhaobo YangFengyuan Che Review Article 15 August 2023 Pages: 1435 - 1454
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways Atefe RahmatiAlireza MafiAmirhossein Sahebkar Review Article 01 August 2023 Pages: 1455 - 1482
Posttransplant cyclophosphamide beyond haploidentical transplantation Leonardo Javier ArcuriAndreza Alice Feitosa RibeiroMariana Nassif Kerbauy Review Article 01 June 2023 Pages: 1483 - 1491
Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects Ali Rajabi ZangiAla AmiriYousef Javadzadeh Review Article 11 November 2023 Pages: 1493 - 1511
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives Ivan KrecakSrdan VerstovsekMarko Lucijanic Review Article 04 September 2023 Pages: 1513 - 1523
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia Eduardo J. Bardón-CanchoJosé Manuel Marco-SánchezElena Cela Original Article Open access 23 March 2024 Pages: 1525 - 1539
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection Yuanfang LiSanjing LiDao Wang Original Article 12 March 2024 Pages: 1541 - 1547
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study Haixia FuXuan Caion behalf of the Collaborative ITP Working Group Research 25 March 2024 Pages: 1549 - 1559
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape Diletta FontanaGiovanni Paolo Maria ZambrottaCarlo Gambacorti-Passerini Original Article Open access 07 February 2024 Pages: 1561 - 1568
Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices Georg-Nikolaus FrankeGunnar LoeweKathleen Jentsch-Ullrich Original Article Open access 12 March 2024 Pages: 1569 - 1575
The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients Chia-Ying WuChiu-Mei YehChia-Jen Liu Original Article Open access 26 March 2024 Pages: 1577 - 1586
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations Evgenii ShumilovPaolo MazzeoUlrike Bacher Original Article Open access 09 January 2024 Pages: 1587 - 1599
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization Li-qiong HouJun-Ru LiuJuan Li Original Article Open access 25 January 2024 Pages: 1601 - 1611
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia Pascal SchlosserAnnett SchiwitzaRainer Claus Original Article Open access 03 February 2024 Pages: 1613 - 1622
How to improve RCHOP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of 21 randomized controlled trials Stergios IntzesMarianthi SymeonidouEmmanouil Spanoudakis Original Article 08 January 2024 Pages: 1623 - 1633
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience Shuchao QinRui JiangHuayuan Zhu Original Article Open access 22 January 2024 Pages: 1635 - 1642
Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma Fei QiYuce WeiJun Zhu Original Article 09 January 2024 Pages: 1643 - 1653
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis Roberta MurruAndrea GalitziaGiovanni Caocci Original Article Open access 18 January 2024 Pages: 1655 - 1664
Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance Sha CuiYinnan GuoJinliang Niu Original Article 07 February 2024 Pages: 1665 - 1673
Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century Li-Ye BeiChun-Yu ShangWei Xu Original Article 16 January 2024 Pages: 1675 - 1685
Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract Rongli XieZekai MaoTiantian Sun Original Article 01 March 2024 Pages: 1687 - 1695
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation Miao ZhouTongyu LiGuifang Ouyang Original Article 27 March 2024 Pages: 1697 - 1704
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation Kazuya TakemuraMika NakamaeHirohisa Nakamae Original Article 18 March 2024 Pages: 1705 - 1715
Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature Santiago MercadalAlberto MussettiDaniel R. Couriel Original Article 02 March 2024 Pages: 1717 - 1727
Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation Zhengqin TianQihang ManJingbo Wang Research 28 March 2024 Pages: 1729 - 1736
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation Yoshihiro UmezawaKota YoshifujiTakehiko Mori Research 21 March 2024 Pages: 1737 - 1744
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population Emily L. GillChristian M. GillColleen McEvoy Research Open access 08 March 2024 Pages: 1745 - 1752
Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians Cordula GebelIsabel KruschelUlrich Wedding Research Open access 28 March 2024 Pages: 1753 - 1763
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report Jian-hui ZhangHui ChenHong Li Case Report 20 March 2024 Pages: 1765 - 1774
Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report Jiawen WangHan ZhuKourong Miao Case Report 01 April 2024 Pages: 1775 - 1777
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report Shuhei KurosawaTakako YokotaTomonori Nakazato Correspondence 21 March 2024 Pages: 1779 - 1781
The impact of statin use on disease-related symptoms in patients with chronic myeloproliferative neoplasms Hrvoje HolikMarko LucijanićIvan Krečak Correspondence 13 March 2024 Pages: 1783 - 1785
Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies? Pasquale NiscolaValentina GianfeliciPaolo de Fabritiis Correspondence 09 March 2024 Pages: 1787 - 1788
Concomitant large deletion and de novo duplication of factor VIII gene in an Indian patient with severe Hemophilia A Debadrita RayRitika SharmaReena Das Correspondence 17 February 2024 Pages: 1789 - 1790
Loeys-Dietz syndrome with concomitant aplastic anemia Qiang ZhaYu ShiWenyi Shen Letter to the Editor 02 February 2024 Pages: 1793 - 1795
Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage Edwin Uriel SuárezMiguel Ángel PirisPilar Llamas Letter to the Editor 03 February 2024 Pages: 1797 - 1799
Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia Yue ChenMengge PanPeipei Xu Correction 27 March 2024 Pages: 1801 - 1801
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study Alexander RöthWilma BarcelliniIlene C. Weitz Correction Open access 23 March 2024 Pages: 1803 - 1803
